Oncology Precision Medicine Recorded Session
The Advocate Aurora Health Oncology Precision Medicine Conference will review the use of molecular testing in molecular tumor boards at Advocate Aurora as well as other health systems. Speakers will discuss OPM from the standpoint of pathology, (tele) genetic counseling and implementation in clinical trials.
If you attended any the live session of Oncology Precision Medicine, you will not be able to claim credit again. You can, however, still watch the content.
Target Audience
This course is intended for Medical Oncologists, Cancer Surgeons, Pathologists, Genetic Counselors, All Medical Staff
Learning Objectives
At the end of this session, learners should be able to:
- Understand the multi-disciplinary nature of oncology precision medicine (OPM)
- Recognize the difficulties including pathology tissue, biomarker validation, and molecular ambiguity detection from testing results
- Appreciate the central importance of genetic counselors in the OPM process
- Review examples of OPM clinical trials and real-world data generation to generate progress and value in oncology
Faculty
Michael A. Thompson, MD, PhD, FASCO Medical Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health
Mary Walters, PharmD, BCOP Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health
James Weese, MD, FACS Vice President of Aurora Cancer Care, Advocate Aurora Health
MJ Luser, Research Coordinator, Aurora Cancer Care, Advocate Aurora Health
Michael P. Mullane, MD Medical Director, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health
Antony Ruggeri, MD Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health
Kristen Hanson, Genetic Counselor Sr, Genomic Medicine, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health
Alicia M Hunt, MD Anatomic & Clinical Pathology, Advocate Aurora Health
Dan Hayes, MD, FACP, FASCO Clinical Director of the Breast Oncology Program, University of Michigan
Frank Zuehl, MD Anatomic & Clinical Pathology, Advocate Aurora Health
Milan Radovich, PhD Co-Director of the IU Health Precision Genomics Program, IU Health Vice- President for Oncology Genomics
Peter O’Dwyer, MD Co-chair ECOG-ACRIN
Edward S. Kim, MD, MBA Physician-In-Chief, City of Hope OC; Immediate Past Chair, ASCO TAPUR Steering Committee
Thomas D. Brown, MD Chief Medical Officer, Syapse
Disclosure
The following faculty speakers and/or planning committee members have disclosed the following:
Faculty Name | Name of Commercial Interest | Nature of Relationship |
Michael Thompson, MD | Adaptive; BMS (Celgene); GRAIL/Illumina; Syapse; Takeda | Advisory Board |
Elsevier | Co-chair, clinical pathways | |
UpToDate | Peer Reviewer | |
Thomas Brown, MD | Sygnomics | Advisor |
GenomiCare | Scientific Advisory Board | |
Novartis | Speakers Bureau | |
Kristen Hanson | Invitae Corporation | Advisory Board Member |
Daniel Hayes, MD | Inbiomotion | Stock Options |
Cepheid; Freenome, Inc.; Artiman Ventures (Cellworks); Agendia, Inc.; Lexent; Epic Sciences, Inc.; Salutogenic Innovations, LLC; L-Nutra; BioVeca; OncoCyte | Consultant | |
Merrimack Pharmaceuticals, Inc.; Eli Lilly Company; Menarini/Silicon BioSystems; Veridex (Johnson & Johnson); Puma Biotechnology, Inc.; Pfizer; Astra Zeneca | Sponsored Clinical Research | |
Janssen R&D, LLC (Johnson & Johnson) | Royalties | |
Immunicon Corporation; University of Michigan | Inventor | |
UpToDate | Editor | |
MedPage | Education Development | |
CancerExpertNow | Expert Panel Member | |
Edward Kim, MD | AZ; Boerhinger Ingelheim; Roche/Genentech | Consulting |
Takeda | Scientific Advisory Board | |
Peter O'Dwyer, MD | Pfizer; Genentech; BMS; AZ; GSK; Five Prime; FortySeven; Merck; Syndax; BBI; Novartis; Celgene; Incyte; Lilly/Imclone; array; h3biomedicine; Taiho; Minneamrat; pharmacyclics/abbvie; Mirati | Research Support |
Genentech; Array | Consulting | |
Bayer; Lilly | Expert Testimony | |
Milan Radovich, PhD | LifeOmic | Scientific Advisor |
Lilly; Boston Biomedical | Principal Investigator | |
Tyme Technologies; Immunomedics; Macrogenics | Investor | |
The other planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. Conflict of interest have been identified and mitigated prior to the activity.
Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Advocate Aurora Health designates this enduring material for a maximum of 3.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Part II
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 3.75 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 3.75 AttendanceAttendance Credit
- 3.75 Approved AMA PRA Category 1 Credit™
- 3.75 ABIM MOC Part IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Price
If you attended any the live session of Oncology Precision Medicine, you will not be able to claim credit again. You can, however, still watch the content.
Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.